In this episode of the Badass Leaders Podcast, host Angela Gill Nelms sits down with Dr. Samir Patel, biotech entrepreneur, co-founder of Clearside Biomedical, and President and CEO of Moonlight Therapeutics, for a candid conversation about entrepreneurship, healthcare innovation, leadership, and the realities of building companies in life sciences.Samir's path to entrepreneurship was anything but planned. Born in India and raised by his grandparents during his early childhood, he later moved to the United States, studied engineering at UC Berkeley, and eventually found his way to Georgia Tech. Research he conducted during his PhD would ultimately become the foundation for Clearside Biomedical, forcing him to choose between the security of a traditional career and the uncertainty of building something entirely new.Samir shares what he learned taking a technology from an academic lab toward commercialization, including why founders need to understand their own strengths, how to build the right leadership team, and why storytelling matters when you're asking investors and employees to believe in a future that doesn't exist yet. He also discusses imposter syndrome and why feeling uncomfortable can actually be evidence that you're continuing to challenge yourself.Learn more about Samir Patel:LinkedIn: https://www.linkedin.com/in/patelsamirkumar/Website: https://www.moonlighttx.com/Twitter / X: https://x.com/MLTherapeuticsOther: https://bme.gatech.edu/academics/masters-programs/ms-biomedical-innovation-and-development-advanced-therapeuticsMentioned in this episode: Moonlight TherapeuticsClearside BiomedicalAtlanta Life Sciences EcosystemThe discussion also tackles questions…How do you turn academic research into a biotech startup?How do scientists successfully transition into entrepreneurship?How do you know when to leave a secure career to start a company?How should founders decide whether they should be the CEO?How do successful leaders deal with imposter syndrome?Why is storytelling important when pitching investors?How do biotech startups raise funding and conserve capital?Why are investor relationships so important for startup founders?What should first-time founders know about building a biotech company?How can founders become more coachable?What makes Atlanta a strong ecosystem for biotech and life sciences startups?How do you build a healthcare product around patients instead of just the technology?What changes when a private biotech company goes public?How do you know when it's time to leave a company you helped build?What lessons should second-time founders carry into their next startup?Key takeaways:Imposter syndrome can be a sign that leaders are still challenging themselves.Successful biotech entrepreneurship requires more than great science.Startup funding is built on relationships, not just investor pitches.Founders should not automatically assume they are the right CEO.Healthcare innovation should improve patients' lives, not simply produce technically successful treatments.Capital-efficient startups resist the pressure to look bigger than they need to be.Taking a biotech company public can fundamentally change the founder's role.Second-time founders have experience, but they still have something to prove to themselves.Atlanta can compete as a biotech and life sciences startup ecosystem.The best founders are coachable enough to know they cannot build alone.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related